20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Bicalutamide for Transgender Health: An Antiandrogen's Role in Feminizing Hormone Therapy

The field of transgender healthcare has seen significant advancements, with hormone therapy playing a crucial role in gender affirmation. Among the medications used, Bicalutamide has emerged as a valuable option for feminizing hormone therapy due to its potent antiandrogenic properties. NINGBO INNO PHARMCHEM CO.,LTD. is committed to supplying high-quality Bicalutamide to support this important area of medical practice.

In individuals assigned male at birth undergoing feminizing hormone therapy, the goal is to reduce the effects of androgens, such as testosterone. Bicalutamide, as a non-steroidal antiandrogen, achieves this by blocking the androgen receptor. This mechanism effectively diminishes the impact of endogenous testosterone, leading to physical changes associated with feminization. The careful consideration of Bicalutamide pharmacokinetic profile and potential Bicalutamide drug interactions is essential for tailoring treatment plans, ensuring both efficacy and safety.

While not its primary approved indication, the use of Bicalutamide in transgender health is a recognized off-label application. The precision of Bicalutamide in antagonizing the androgen receptor makes it an attractive choice for managing androgen levels. Healthcare providers often monitor patients undergoing Bicalutamide treatment for efficacy and any potential side effects, which, while generally well-tolerated, can include effects on liver function. NINGBO INNO PHARMCHEM CO.,LTD. ensures our Bicalutamide meets the quality standards necessary for these sensitive applications.

As a dedicated Bicalutamide supplier, NINGBO INNO PHARMCHEM CO.,LTD. supports the growing need for this medication in transgender healthcare. We understand the importance of reliable access and competitive Bicalutamide drug price. By providing consistent quality and supporting research into Bicalutamide clinical trials and applications, we aim to contribute positively to the well-being and affirmation of transgender individuals worldwide. Our commitment as a Bicalutamide manufacturer is to facilitate access to essential therapies.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: The Precision of Bicalutamide in Androgen Receptor Signaling: A Focus for Research

Next: The Crucial Role of Perindopril Intermediates in Cardiovascular Drug Manufacturing

All Rights Reserved